Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
MPR News Presents
MPR News Staff

Intelligence Squared debate: Is the Defense Production Act being underutilized?

General Motors
The GM logo is seen at the General Motors Arlington Assembly Plant in Arlington, Texas.
Tom Pennington/Getty Images

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

President Trump recently invoked the Defense Production Act to compel a Maine-based company to produce swabs for coronavirus testing. This law, which dates back to the Korean War, gives the federal government considerable authority to compel private companies to produce materials in the interest of national defense.

While the administration has employed this law in recent weeks, many are calling on the government to do much more. In fact, Joe Biden said that the president's underuse of the act is a "national disgrace."

What is the Defense Production Act? And how might the government help medical professionals get access to the supplies they need to combat coronavirus?

John Donvan hosted two of the nation's leading experts on the DPA in the IQ2 first-ever "at-home debate.” Historian of American production Margaret O'Mara and national security expert Thomas Spoehr took on the motion, "The Defense Production Act is being underutilized."

Here are a few things they mentioned:

  • Despite being a lesser-known law, the Defense Production Act has been invoked not hundreds, but hundreds of thousands of times since it was established 70 years ago.

  • For the motion: Margaret O’Mara, author of “The Code,” argued that the private sector isn’t meeting the demands of the crisis on its own. Even the most successful companies in the world, like Amazon, have major shortages and delays.

  • Against the motion: Thomas Spoehr, director of the Heritage Foundation’s Center for National Defense, said that despite any initial shortcomings, the United States remains the best model in combating coronavirus. The unique system of free enterprise, where customers and producers self-connect, is what led to success during and after World War II, and can be replicated.